MiMedx Group, Inc. Increase (Decrease) in Income Taxes Receivable
MiMedx Group, Inc. (MDXG) reported Increase (Decrease) in Income Taxes Receivable of -$39.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2023-02-28
- MiMedx Group, Inc. increase (decrease) in income taxes receivable for the quarter ending 2022-12-31 was -$52.00K, a 144.07% decline year-over-year.
- MiMedx Group, Inc. increase (decrease) in income taxes receivable for the quarter ending 2022-09-30 was -$53.00K.
- MiMedx Group, Inc. increase (decrease) in income taxes receivable for the quarter ending 2022-06-30 was $129.00K, a 12.24% decline year-over-year.
- MiMedx Group, Inc. increase (decrease) in income taxes receivable for the quarter ending 2022-03-31 was -$63.00K.
- MiMedx Group, Inc. increase (decrease) in income taxes receivable for fiscal 2022 was -$39.00K.
- MiMedx Group, Inc. increase (decrease) in income taxes receivable for fiscal 2021 was -$9.30M, a 192.77% decline from fiscal 2020.
- MiMedx Group, Inc. increase (decrease) in income taxes receivable for fiscal 2020 was $10.03M.
- MiMedx Group, Inc. increase (decrease) in income taxes receivable for fiscal 2019 was -$436.00K.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$105.00K derived: sum of 2 quarters · filed 2023-02-28 | $24.00K derived: sum of 3 quarters · filed 2023-02-28 | -$39.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | -$53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $76.00K derived: sum of 2 quarters · filed 2022-11-02 | $13.00K 10-Q · filed 2022-11-02 | $131.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $66.00K 10-Q · filed 2022-08-02 | $184.00K derived: sum of 3 quarters · filed 2023-02-28 | -$9.33M derived: sum of 4 quarters · filed 2023-02-28 |
| 2022-03-31 | -$63.00K 10-Q · filed 2022-05-03 | $55.00K derived: sum of 2 quarters · filed 2023-02-28 | -$9.46M derived: sum of 3 quarters · filed 2023-02-28 | -$9.31M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-12-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$9.39M derived: sum of 2 quarters · filed 2023-02-28 | -$9.25M derived: sum of 3 quarters · filed 2023-02-28 | -$9.30M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$9.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$9.37M derived: sum of 2 quarters · filed 2022-11-02 | -$9.42M 10-Q · filed 2022-11-02 | -$10.23M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $93.00K 10-Q · filed 2022-08-02 | -$715.00K derived: sum of 3 quarters · filed 2023-02-28 | -$562.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$54.00K 10-Q · filed 2022-05-03 | -$862.00K derived: sum of 2 quarters · filed 2023-02-28 | -$709.00K derived: sum of 3 quarters · filed 2023-02-28 | -$738.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$808.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$655.00K derived: sum of 2 quarters · filed 2023-02-28 | -$684.00K derived: sum of 3 quarters · filed 2023-02-28 | $10.03M 10-K · filed 2023-02-28 |
| 2020-09-30 | $153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $124.00K derived: sum of 2 quarters · filed 2021-11-02 | $10.84M 10-Q · filed 2021-11-02 | $10.01M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $10.68M 10-Q · filed 2021-08-03 | $9.86M derived: sum of 3 quarters · filed 2022-02-28 | $10.17M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $10.71M 10-Q · filed 2021-04-28 | $9.89M derived: sum of 2 quarters · filed 2022-02-28 | $10.20M derived: sum of 3 quarters · filed 2022-02-28 | $10.26M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$825.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$516.00K derived: sum of 2 quarters · filed 2022-02-28 | -$448.00K derived: sum of 3 quarters · filed 2022-02-28 | -$436.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $309.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $377.00K derived: sum of 2 quarters · filed 2020-11-04 | $389.00K 10-Q · filed 2020-11-04 | $399.00K derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-06-30 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $80.00K 10-Q · filed 2020-08-04 | $90.00K derived: sum of 3 quarters · filed 2021-03-08 | $533.00K derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-03-31 | $12.00K 10-Q · filed 2020-07-06 | $22.00K derived: sum of 2 quarters · filed 2021-03-08 | $465.00K derived: sum of 3 quarters · filed 2021-03-08 | -$349.00K derived: sum of 4 quarters · filed 2021-03-08 |
| 2018-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $453.00K derived: sum of 2 quarters · filed 2021-03-08 | -$361.00K derived: sum of 3 quarters · filed 2021-03-08 | -$202.00K 10-K · filed 2021-03-08 |
| 2018-09-30 | $443.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-06 | -$371.00K derived: sum of 2 quarters · filed 2020-07-06 | -$212.00K 10-Q · filed 2020-07-06 | |
| 2018-06-30 | -$814.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-06 | -$655.00K 10-Q · filed 2020-07-06 | ||
| 2018-03-31 | $159.00K 10-Q · filed 2020-07-06 | |||
| 2017-12-31 | $656.00K 10-K · filed 2020-07-06 | |||
| 2016-12-31 | $0.00 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |